On the Record · Alere
Alere acquisitions, on the record
The businesses Alere bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.
Deals its annual reports describe
| Business | Deal | When | Value |
|---|---|---|---|
health management businessWord for word“On January 9, 2015, we completed the sale of our condition management, case management, wellbeing, wellness, and women’s and children’s health businesses, which we refer to collectively as 2 Table of Contents our health management business, to OptumHealth Care Solutions for a purchase price of $600.1 million, subject to a customary post-closing working capital and net cash adjustment.” 10-K for 2014 | divestiture | On January 9, 2015 | $600.1 million |
vitamins and nutritional supplements businessWord for word“On January 15, 2010, we completed the sale of our vitamins and nutritional supplements business.” 10-K for 2014 | divestiture | On January 15, 2010 | — |
Vedalab S.A. (40% interest)Word for word“Loss on sale of our 40% interest in Vedalab S.A., or Vedalab, was in the amount of $0.4 million.” 10-K for 2014 | divestiture | — | — |
BBI business (subsidiary BBI Diagnostic Group Ltd.)Word for word“On November 17, 2015, we completed the sale of our BBI business, which was achieved through the sale of our subsidiary BBI Diagnostic Group Ltd., for a purchase price of approximately $106.4 million, net of a final working capital adjustment.” 10-K for 2015 | agreed divestiture | On November 17, 2015 | approximately $106.4 million |
US Diagnostics, Inc. (USD)Word for word“On July 10, 2015, we acquired substantially all of the assets of US Diagnostics, Inc., or USD, located in Huntsville, Alabama, a provider of instant on-site drug testing products designed for quick and accurate drug test results.” 10-K for 2015 | acquisition | On July 10, 2015 | — |
ACS (Alere Accountable Care Solutions, LLC, health information exchange business)Word for word“On October 10, 2014, we completed the sale of ACS, our health information exchange business, to ACS Acquisition, LLC for a purchase price consisting primarily of contingent consideration.” 10-K for 2015 | divestiture | On October 10, 2014 | — |
Wellogic ME FZ – LLCWord for word“In connection with the sale of ACS, in June 2015 we also sold our subsidiary Wellogic ME FZ – LLC, or Wellogic, which we refer to collectively with ACS, as the ACS Companies, to the same purchaser.” 10-K for 2015 | divestiture | in June 2015 | — |
| Fiscal year ended | Cash paid for acquisitions (net of cash acquired) |
|---|---|
| 2016-12-31 | $6 million |
Deal filings since 2016
- 2017-10-03 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
- 2017-09-19 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2017-07-17 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2017-05-30 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2017-04-24 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2017-04-14 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-08-18 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-04-28 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-02-01 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
Read from Alere’s annual reports (10-K for 2016, 10-K for 2015, 10-K for 2014) and the financial data it files with the SEC, as of 2017-06-05. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.